Patent ID: 9150519
Filing Date: 2015-10-06
Classification: A61P,C07D

Abstract:
1. A method of treating an immunoregulatory abnormality comprising the administration of a composition to a subject having said abnormality, said composition comprising compound according to formula (I): wherein X is NR R R A is branched or linear alkyl having 1 to 12 C-atoms, wherein one or more H-atoms may be replaced by Hal, OR Hal is F, Cl, Br or I, W is C═O, C═S, SO Q is NR Het denotes a bicyclic, aromatic heterocyclic ring having 2 N atoms which may be unsubstituted, monosubstituted, disubstituted or trisubstituted by Hal, A, OR R R R N is 0, 1, 2, 3, 4, 5, 6, 7 or 8, or pharmaceutically acceptable derivatives, solvates, tautomers, salts, stereoisomers or mixtures thereof.